Jubilant Pharmova share news, announcements and annual reports
NSE: JUBLPHARMABSE: 530019Pharmaceuticals & BiotechnologySmall Cap
Jubilant Pharmova Limited · Formerly Jubilant Life Sciences · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jun 1981 on BSE, Jun 2003 on NSE
Last close ₹959.80up ₹22.80 (2.43%)BSE ₹955.75
Share price at the NSE close on 27 Oct 2026. Previous close ₹937.00.
27 Oct: open ₹939.80, high ₹965.90, low ₹931.40
52-week range of traded prices to 27 Oct 2026
₹786.05Low, 9 Mar 2026₹1,183.00High, 4 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹15,288 Cr422nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 43.42
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹59 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 37.17
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.16
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.52%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 5.3%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹59 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 6.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 7.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.45
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,43,47353.0% delivered
Jubilant Pharmova board meetings
112 filed, newest first. Page 1 of 3.
Oct 2026
Aug 2026
Jul 2026
30 Jul · Board meeting
Not held on this date
May 2026
22 May · Board meeting
22 May · Board meeting
Apr 2026
Jan 2026
22 Jan · Board meeting
Oct 2025
31 Oct · Board meeting
14 Oct · Board meeting
Sep 2025
23 Sep · Board meeting
Jul 2025
23 Jul · Board meeting
Apr 2025
Jan 2025
31 Jan · Board meeting
23 Jan · Board meeting
Oct 2024
25 Oct · Board meeting
17 Oct · Board meeting
Jul 2024
19 Jul · Board meeting
10 Jul · Board meeting
May 2024
Mar 2024
26 Mar · Board meeting
Feb 2024
2 Feb · Board meeting
Jan 2024
23 Jan · Board meeting
Oct 2023
27 Oct · Board meeting
19 Oct · Board meeting
Jun 2023
27 Jun · Board meeting
May 2023
Jan 2023
25 Jan · Board meeting
Oct 2022
Jul 2022
May 2022
Jan 2022
27 Jan · Board meeting
Oct 2021
14 Oct · Board meeting
Jul 2021
23 Jul · Board meeting
15 Jul · Board meeting
May 2021
Jan 2021
29 Jan · Board meeting
Nov 2020
4 Nov · Board meeting
Oct 2020
Aug 2020
May 2020
29 May · Board meeting
Feb 2020
20 Feb · Board meeting
Jan 2020
Oct 2019
25 Oct · Board meeting
17 Oct · Board meeting
Jul 2019
19 Jul · Board meeting
May 2019